Program: Education Program
Session: Monoclonal Gammopathies of Determined Significance
Hematology Disease Topics & Pathways:
multiple myeloma, Biological, antibodies, therapy sequence, Adult, Diseases, smoldering myeloma, Non-Biological, Therapies, Combinations, chemotherapy, Plasma Cell Disorders, immunotherapy, Lymphoid Malignancies, Study Population, Clinically relevant
Session: Monoclonal Gammopathies of Determined Significance
Hematology Disease Topics & Pathways:
multiple myeloma, Biological, antibodies, therapy sequence, Adult, Diseases, smoldering myeloma, Non-Biological, Therapies, Combinations, chemotherapy, Plasma Cell Disorders, immunotherapy, Lymphoid Malignancies, Study Population, Clinically relevant
Sunday, December 6, 2020, 1:55 PM-2:00 PM
Disclosures: Palladini: Jannsen Cilag: Honoraria, Other; Celgene: Other: Travel support.
OffLabel Disclosure:
Previous Presentation
|
Next Presentation >>